KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Rituximab (Rituxan) (10)

Friday
Apr012011

NCT01329354

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkins Follicular Lymphoma in Response to First Line Chemotherapy

Conditions: Non-Hodgkin Lymphoma
Sponsors: Clinica Universidad de Navarra, Universidad de Navarra
Phase: II
 

Tuesday
Jul312007

NCT00510471

Wednesday
May102006

NCT00324831

Wednesday
Jan042006

NCT00282308

Tuesday
Nov222005

NCT00258336

Wednesday
Apr132005

2004-004774-85

Monday
Aug232004

NCT00090038

Wednesday
Aug042004

NCT00089115

Tuesday
Nov042003

NCT00071955

Tuesday
May062003

NCT00060164

Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma

Conditions:  Lymphoma
Sponsors:  Univeristy Hospitals Seidman Cancer Center, National Cancer Institute (NCI)
Phase II